Management Options for Biochemically Recurrent Prostate Cancer.

Area of Science:

• Urology
• Oncology
• Medical Imaging

Background:

• Prostate cancer is a common malignancy in men.
• Biochemical recurrence after initial treatment affects about one-third of patients.
• Current management guidelines for recurrent prostate cancer are not uniform.

Purpose of the Study:

• To review current management strategies for biochemically recurrent prostate cancer.
• To discuss emerging diagnostic and therapeutic options.

Main Methods:

• Literature review of available data and retrospective studies.
• Discussion of salvage therapies, androgen deprivation therapy (ADT), and intermittent vs. continuous ADT.
• Exploration of novel imaging techniques and alternative treatments.

Main Results:

• Salvage radiation or prostatectomy are initial considerations for curative intent.
• Androgen deprivation therapy (ADT) is a standard option for disease control.
• Intermittent ADT may be a reasonable option for men with biochemical recurrence, balancing efficacy and side effects.

Conclusions:

• Management of biochemically recurrent prostate cancer requires individualized approaches.
• Emerging imaging technologies like PSMA may improve disease monitoring.
• Investigational therapies like herbal agents and immunotherapy offer potential alternatives to ADT with reduced toxicity.